Results per Page:
High-throughput sequencing outpaces flow cytometry for earliest detection of cancer relapse
Next-generation, high-speed DNA-decoding technology detects minimal residual disease in nearly double the number of leukemia patients than current gold standard method
Detecting earliest signs of cancer relapse: Study finds high-throughput sequencing outpaces flow cytometry
Next-generation, high-speed DNA-decoding technology detects minimal residual disease in nearly double the number of leukemia patients than current gold standard method